[1]
FILHO, A.C.V.A. et al. 2014. GAMMA-ORYZANOL HAS AN EQUIVALENT EFFICACY AS A LIPID-LOWERING AGENT COMPARED TO FIBRATE AND STATIN IN TWO DYSLIPIDEMIA MICE MODELS. International Journal of Pharmacy and Pharmaceutical Sciences. 6, 11 (Nov. 2014), 61–64.